BioCentury
ARTICLE | Clinical News

CD-NP: Phase II data

November 22, 2010 8:00 AM UTC

A single-blind, placebo-controlled Phase II trial in 77 patients with ADHF and mild to moderate renal insufficiency showed that 1.25, 2.5 and 3.75 ng/kg/min infusions of CD-NP administered for up to 7...